In its motion, the House really linked the vaccine development and the contractual negotiations. It said that this ground of “information the disclosure of which could reasonably be expected to interfere” would apply with respect to paragraph (y). Paragraph (y) is the paragraph on the vaccine task force.
I think the House accepted and understood that when you're dealing with this vaccine development issue, there is a risk that there is contractual information that needs to be kept confidential so that it doesn't harm that relationship between the government and the vaccine developers. The House has agreed that this is a valid reason to keep information confidential.
If the prioritization results in those types of documents being looked at first, I would expect to see that ground come up. I would expect that this is where you would see this issue being raised as information that should be kept confidential.